We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IKNA market cap is 63.22M. The company's latest EPS is USD -1.4125 and P/E is -0.93.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.4M | 5.45M | 5.31M | 2M | 1.19M |
| Operating Income | -17.88M | -15.11M | -15.52M | -18.49M | -19.5M |
| Net Income | -17.34M | -14.1M | -14.22M | -17.12M | -17.34M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.75M | 9.19M | 30.99M | 15.62M | 9.16M |
| Operating Income | -18.49M | -44.52M | -34.14M | -70.9M | -75.42M |
| Net Income | -16.82M | -44.26M | -34.12M | -68.77M | -68.17M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 190.47M | 172.26M | 152.4M | 171.76M | 215.34M |
| Total Liabilities | 31.68M | 25.29M | 17.38M | 15.06M | 28.15M |
| Total Equity | 158.79M | 146.97M | 135.02M | 156.7M | 155.34M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 85.97M | 168.4M | 247.88M | 172.26M | 192.09M |
| Total Liabilities | 68.57M | 63.47M | 40M | 25.29M | 22.34M |
| Total Equity | -61.46M | -101.05M | 207.88M | 146.97M | 169.76M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -56.45M | -74.11M | -19.78M | -37.93M | -57.92M |
| Investing | -109.78M | -99.28M | -10.81M | 11.87M | 43.77M |
| Financing | 1.09M | 1.1M | N/A | 37M | 75.92M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 47.93M | -37.83M | -60.25M | -74.11M | -79.74M |
| Investing | -316k | 2.92M | -1.76M | -99.28M | 64.14M |
| Financing | 16.32M | 116.18M | 131.74M | 1.1M | 75.98M |
| Market Cap | 63.22M |
| Price to Earnings Ratio | -0.93 |
| Price to Sales Ratio | 6.9 |
| Price to Cash Ratio | 0.53 |
| Price to Book Ratio | 0.37 |
| Dividend Yield | - |
| Shares Outstanding | 48.26M |
| Average Volume (1 week) | 208.78k |
| Average Volume (1 Month) | 226.41k |
| 52 Week Change | -82.05% |
| 52 Week High | 7.58 |
| 52 Week Low | 1.02 |
| Spread (Intraday) | 0.06 (4.48%) |
| Company Name | Ikena Oncology Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.ikenaoncology.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
